Dendritic cells pulsed with peptides of gp63 induce differential protection against experimental cutaneous leishmaniasis

International Journal of Immunopathology and Pharmacology

Volumn 17, Issue 3, 2004, Pages 343-352

  Tsagozis, P ^a   Karagouni, E ^a   Dotsika, E ^a  

^a HELLENIC PASTEUR INSTITUTE   (Greece)

Author keywords

Dendritic cells; Leishmania major; Th1 Th2 polarization; Vaccination

Indexed keywords

GAMMA INTERFERON; GLYCOPROTEIN; INTERLEUKIN 4; LEISHMANIA VACCINE; PARASITE ANTIGEN; PEPTIDE 154-169AA; PROTEIN P63; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CELL LYSATE; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; DISEASE COURSE; DRUG EFFICACY; DRUG SYNTHESIS; GENETIC RESISTANCE; GENETIC SUSCEPTIBILITY; IMMUNE RESPONSE; IMMUNOBIOLOGY; INFECTION; INFECTION PREVENTION; LEISHMANIA MAJOR; MORBIDITY; MORTALITY; MOUSE; NONHUMAN; PARASITE IMMUNITY; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROMASTIGOTE; SKIN LEISHMANIASIS; TH2 CELL; VACCINE PRODUCTION;

EID: 8344267581     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200401700314     Document Type: Article

References (45)

1. Herwaldt B.L. 1999. Leishmaniasis. Lancet 354:1191.
2. Reed S.G. and P. Scott. 1993. T-cell and cytokine responses in leishmaniasis. Curr. Opin. Immunol. 5:524.
3. Reiner S.L. and R.M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151.
4. Frydas S., B. Madhappan and D. Kempuraj. 2002. Some aspects of Parasitology and Immunology in general Medicine. Int. J. Immunopathol. Pharmacol. 15:165.
5. Frydas S., M. Hatzistilianou, E. Karagouni, B. Madhappan, N. D'Orazio, G. Riccioni, F. Conti, G. Carratelli and D. Kempuraj. 2003. Chemokines and parasites. Int. J. Immunopathol. Pharmacol. 16:221.
6. Banchereau J. and R.M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245.
7. Banchereau J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y.J. Liu, B. Pulendran and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767.
8. H2 development. Nature Immunol. 1:199.
9. Puledran B., J.L. Smith, G. Caspary, K. Brasel, D. Pettit, E. Maraskovsky and C.R. Maliszewski. 1999. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc. Natl. Acad. Sci. U S A 96:1036.
10. Kalinski P., C.M.U. Hilkens, E.A. Wierenga and M.L. Kapsenberg. 1999. T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol. Today 20:565.
11. Kasahara S., H. Fugo, E.L. Cooper and H. Wago. 2001. Preliminary evidence of modulating Th1 cytokine after allergen challenge. Int. J. Immunopathol. Pharmacol. 14:63.
12. Moll H. and C. Berberich. 2001. Dendritic cell-based vaccination strategies: induction of protective immunity against leishmaniasis. Immunobiol. 204:659.
13. Flohé S.B., C. Bauer, S. Flohé and H. Moll. 1998. Antigen-pulsed epidermal Langerhans cells protect susceptible mice from infection with the intracellular parasite Leishmania major. Eur. J. Immunol. 28:3800.
14. Konecny P., A.J. Stagg, H. Jebbari, N. English, R.N. Davidson and S.C. Knight. 1999. Murine dendritic cells internalize Leishmania major promastigotes, produce IL-12p40 and stimulate primary T cell proliferation in vitro. Eur. J. Immunol. 29:1803.
15. Von Stebut E., Y. Belkaid, T. Jakob, D.L. Sacks and M.C. Udey. 1998. Uptake of Leishmania major amastigotes results in activation and Interleukin 12 release from murine skin-derived Dendritic cells: Implications for the initiation of anti-Leishmania immunity. J. Exp. Med. 188:1547.
16. Von Stebut E., Y. Belkaid, B.V. Nguyen, M. Cushing, D. Sacks and M.C. Udey. 2000. Leishmania major-infected murine Langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous leishmaniasis. Eur. J. Immunol. 30:3498.
17. Ahuja S.S., R.L. Reddick, N. Saoto, E. Montalbo, V. Kostecki, W.J. Dolan, P.C. Melby and S.K. Ahuja. 1999. Dendritic cell (DC)-based anti-infective strategies: DCs engineered to secrete IL-12 are a potent vaccine in a murine model of an intracellular infection. J. Immunol. 163:3890.
18. Berberich C., J.R. Ramirez-Pineda, C. Hambrecht, G. Alber, T.A. Skeiky and H. Moll. 2003. Dendritic cell (DC)-based protection against an intracellular pathogen is dependent upon DC-derived IL-12 and can be induced by molecularly defined antigens. J. Immunol. 170:3171.
19. Connell N.D., E. Medina-Acosta, W.R. McMaster, B.R. Bloom and D.G. Russell. 1993. Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guerin expressing the Leishmania surface proteinase gp63. Proc. Natl. Acad. Sci. U S A 90:11473.
20. McSorley S.J., D. Xu and F.Y. Liew. 1997. Vaccine efficacy of Salmonella strains expressing glycoprotein 63 with different promoters. Infect. Immun. 65:171.
21. Papadopoulou G., E. Karagouni and E. Dotsika. 1998. ISCOMs vaccine against experimental leishmaniasis. Vaccine 16:885.
22. Russell D.G. and J. Alexander. 1988. Effective immunization against cutaneous leishmaniasis with defined membrane antigens reconstituted into liposomes. J. Immunol. 140:1274.
23. Xu D., S.J. McSorley, S.N. Chatfield, G. Dougan and F.Y. Liew. 1995. Protection against Leishmania major infection in genetically susceptible BALB/c mice by gp63 delivered orally in attenuated Salmonella typhimurium (AroA- AroD-). Immunol. 85:1.
24. Jardim A., J. Alexander, H.S. Teh, D. Ou and R.W. Olafson. 1990. Immunoprotective Leishmania major synthetic T-cell epitopes. J. Exp. Med. 172:645.
25. Spitzer N., A. Jardim, D. Lippert and R.W. Olafson. 1999. Long-term protection of mice against Leishmania major with a synthetic peptide vaccine. Vaccine 17:1298.
26. Frankenburg S., O. Axelrod, S. Kutner, C.L. Greenblatt, S.N. Klaus, E.A. Pirak, R. McMaster and G.H. Lowell. 1996. Effective immunization of mice against cutaneous leishmaniasis using an intrinsically adjuvanted synthetic lipopeptide vaccine. Vaccine 14:923.
27. Lutz M.B., N. Kukutsch, A.L. Ogilvie, S. Robner, F. Koch, N. Romani and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Meth. 223:77.
28. Hitoglou S., S. Frydas, M. Hatzistilianou, S. Pappa, D. Gougoustamou and A. Kotsis. 2004. Response of ADA and its isoenzymes in mice infected by Trichinella spiralis and treated with mimosine. Int. J. Immunopathol. Pharmacol. 17:191.
29. Petruzzi M., M. De Bebedittis, M.P. Loria, P. Dambra, L. D'Oronzio, C. Capuzzimati, A. Tursi, L. Lo Muzio and R. Serpico. 2004. Immune response in patients with oral lichen planus and HCV infection. Int. J. Immunopathol. Pharmacol. 17:93.
30. Kempuraj D., R.S. Devi, B. Madhappan, P. Conti, M.Y. Nazer, S. Christodoulou, J. Reginald, N. Suthinthirarajan and A. Namasivayam. 2004. T lymphocyte subsets and immunoglobulins in intracranial tumor patients before and after treatment, and based on histological type of tumors. Int. J. Immunopathol. Pharmacol. 17:57.
31. Titus R.G., M. Marchand, T. Boon and J.A. Louis. 1985. A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol. 7:545.
32. Vecchiet J., M. Dalessandro, F. Travasi, K. Falasca, A. Di Iorio, C. Schiavone, P. Zingariello, E. Di Ilio and E. Pizzigallo. 2003. Interleukin-4 and interferon-gamma production during HIV-1 infection and changes induced by antiretroviral therapy. Int. J. Immunopathol. Pharmacol. 16:157.
33. Frydas S., Y. Theodoridis, T.S. Rallis, I. Hatzistilianou, K.K. Adamama - Moraitou, D. Paludi, S. Di Luzio, L. Castellani, A. Grilli and M. Di Gioacchino. 2001. Leishmania antibodies in childrens serum samples in correlation with the disease in dogs. Int. J. Immunopathol. Pharmacol. 14:173.
34. Frydas S., N. Papaioannou, M. Papazachariadou, M. Xatzistilianou, I. Vlemmas, D. Merlitti, M.L. Castellani, C. Schiavone, A. Tulli and M. Di Gioacchino. 2002. A spectrum of antibody (IgG. IgG1, IgM) response in mice infected with Trichinella spiralis treated with L-mimosine. Int. J. Immunopathol. Pharmacol. 15:19.
35. Yoshino S., H. Hayashi, S. Taneda, H. Takano, M. Sagai and Y. Mori. 2002. Effects of diesel exhaust particle extracts on Th1 and Th2 immune responses in mice. Int. J. Immunopathol. Pharmacol. 15:13.
36. Moll H. and C. Berberich. 2001. Dendritic cells as vectors for vaccination against infectious diseases. Int. J. Med. Microbiol. 295:323.
37. Fong L. and E.G. Engelman. 2000. Dendritic cells in cancer immunotherapy. Annu. Rev. Immunol. 18:245.
38. Paul S., A. Sodhi and S.K. Biswas. 2000. Activation of murine bone-marrow derived macrophages in vitro with Thymosin-alpha-1 to tumoricidal state: a comparative study on normal and tumour-bearing hosts. Int. J. Immunopathol. Pharmacol. 13:129.
39. Moll H., S. Flohe and M. Rollinghof. 1995. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen- specific T cell immune response. Eur. J. Immunol. 25:693.
40. Vieira P.L., E.C. de Jong, E.A. Wierenga, M.L. Kapsenberg and P. Kalinski. 2000. Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction. J. Immunol. 164:4507.
41. Kempuraj D., S. Frydas, P. Conti, K. Kandere, W. Boucher, R. Letourneau, B. Madhappan, S.H. Huang, S. Koreaki, S. Christodoulou and T.C. Theoharides. 2003. Interleukin-25: a new IL-17 family member with growth factor/inflammatory action. Int. J. Immunopathol. Pharmacol. 16:185.
42. Lanzavecchia A. and F. Sallusto. 2001. Regulation of T cell immunity by dendritic cells. Cell 106:263.
43. Lanzavecchia A. and F. Sallusto. 2001. The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics. Curr. Opin. Immunol. 13:291.
44. Kaneider N.C., A. Kaser, H. Tilg, G. Ricevuti and C.J. Wiedermann. 2003. CD40 ligand-dependent maturation of human monocyte-derived dendritic cells by activated platelets. Int. J. Immunopathol. Pharmacol. 16:225.
45. Moser M. and K.M. Murphy. 2000. Dendritic cell regulation of TH1-TH2 development. Nat. Immunol. 1:199.